24 year outcomes of hepatitis B vaccination in Hangzhou, China

Figures & data

Table 1. Incidence and mortality of hepatitis b in Hangzhou city in 1990–2013

	Incidence		Mortality
Year	N	(/one hundred thousand)	N	(/one hundred thousand)	Proportion of total hepatitis (%)
1990	5466	95.41	13	0.23	28.97
1991	5730	99.35	16	0.28	36.12
1992	5572	95.98	17	0.29	37.17
1993	4101	70.13	15	0.26	37.77
1994	3631	61.54	15	0.25	41.68
1995	3869	64.98	14	0.24	51.33
1996	4185	69.68	13	0.22	47.39
1997	3898	64.37	11	0.18	55.43
1998	3746	61.43	31	0.51	62.14
1999	3505	57.1	20	0.33	62.52
2000	3216	51.97	16	0.25	67.03
2001	3074	49.16	1	0.01	71.17
2002	2063	32.59	1	0.02	65.78
2003	1726	26.98	1	0.02	59.62
2004	2287	35.66	1	0.02	89.16
2005	1665	22.94	2	0.03	90.64
2006	1388	19.05	0	0	91.26
2007	1111	15.01	1	0.01	82.17
2008	1042	13.87	0	0	87.56
2009	961	12.66	1	0.01	86.58
2010	780	10.17	0	0	90.49
2011	890	10.23	0	0	87.68
2012	763	8.78	0	0	87.8
2013	668	7.62	0	0	85.86

Figure 1. Urban-rural incidence of hepatitis B (/100,000) in Hangzhou in 1990–2013.

Figure 2. The age distribution of hepatitis B in Hangzhou in 1990, 2006 and 2013.

Figure 3. The occupations distribution of hepatitis B in Hangzhou in 1990, 2006 and 2013.

Figure 4. Incidence of hepatitis B (/100,000) and HepB vaccination rate in Hangzhou in 1990–2013.

Figure 5. Comparison of the age-specific prevalence rate of (A) HBsAg, (B) Anti-HBs, and (C) Anti-HBc among people in 2006 in Hangzhou.